Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00527917
Status:
COMPLETED
Last Update Posted:
2009-12-09
First Post:
2007-09-07
Brief Title:
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst Versus Placebo in Patients With Interstitial CystitisPainful Bladder Syndrome
Sponsor:
Watson Pharmaceuticals
Organization:
Watson Pharmaceuticals
Organization Data
Organization:
Watson Pharmaceuticals
Class:
INDUSTRY
Study ID:
UR07001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Watson Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gary Hoel PhD Executive Director
Old Organization:
Watson Laboratories Inc